Piper Jaffray Neutral On Thoratec

Piper Jaffray has a Neutral rating and a $27 price target on shares of Thoratec Corporation THOR after it reported earnings. In a note to clients, Piper Jaffray writes, "Considering the significant beat in Q2 and the announced acquisition of Levitronix ($4M in acquired sales), we expect both our revenue and EPS estimates to move higher. We will update our model after we have results from HTWR on Thurs afternoon and a better understanding of the market dynamics between the two players. Shares of THOR gained 60 cents yesterday to close at $33.85.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHealth Care EquipmentPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!